IO Biotech was named to Fast Company’s World’s Most Innovative Companies of 2025 list for its potentially game-changing approach to immune-modulatory cancer vaccines, earning its place on the coveted ...

Three stocks that are struggling today are Alphabet (NASDAQ: GOOG)(NASDAQ: GOOGL), Merck (NYSE: MRK), and Block (NYSE: XYZ).

Merck filed for approval of gefapixant in March 2021 on the strength of a pair of phase 3 trials – COUGH-1 and COUGH-2 – which found that the drug reduced 24-hour cough frequency by 18% and 15 ...

It's a companion shot to Merck's Vaxneuvance (formerly V114), which covers 15 serotypes and was approved by the FDA last year as a rival to Pfizer's Prevnar 13 and newer Prevnar 20 vaccines, which ...

The ABA Center for Innovation is a place for collaborative and creative thinking about transforming the US justice system. We believe the intersection of law and technology affords the profession a ...